Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.24.1.u1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Operating activities    
Net loss - including non-controlling interest $ (381,571) $ (768,351)
Adjustments to reconcile net loss to net cash (used in) operations    
Amortization of debt discount 11,341 14,768
Amortization of expense on note receivable (3,308)
Provision for credit losses 174,214
Net loss from equity method investment 43,812
Unrealized (gain) on available - for - sale securities 40,896 401,249
Gain on disposal of non-controlling investment (83,064)
(Increase) decrease in    
Accounts receivable 45,000 (45,000)
Interest receivable 2,218
Prepaids
Increase (decrease) in    
Accounts payable and accrued expenses 161,832 209,989
Accounts payable and accrued expenses - related party 60,000
Accumulated losses on unconsolidated investees in excess of investment 1,226
Net cash (used in) provided by operating activities (122,502) 7,753
Net (decrease) increase in cash (122,502) 7,753
Cash and cash equivalents - beginning of period 235,311 227,558
Cash and cash equivalents - end of period 112,809 235,311
Supplemental disclosure of cash flow information    
Cash paid for interest
Cash paid for income tax
Supplemental disclosure of non-cash operating activities    
Reversal of accrued expense payable 40,165
Total non-cash operating activities $ 40,165